← Leaderboards
Roberto Ciccocioppo
Medical University Of South Carolina
$3,041,278
Attributed
$10,770,267
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2018–24$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,770,267 · 2
By mechanism
UG3$6,654,182 · 1
U01$4,116,085 · 1
Top collaborators
- Dongjun Chung5 shared
- Gerard Thomas Hardiman5 shared
- Peter W Kalivas5 shared
- Leah Catherine Solberg Woods5 shared
- Mark K. Greenwald2 shared
- Joseph Grieco2 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Gerard Thomas Hardiman$823,217
- Carla Kmett Danielson$14,901,808
- W David Bradford$4,440,798
- Elizabeth J Letourneau$8,452,351
- Harold L Haun$225,814
Others in their field
Other Emerging Leaders on “Rattus”
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,543,727
- Xinhua Li · Nano Terra, Inc.$23,579,188
- Barney Sparrow · Battelle Memorial Institu$16,547,191
- Vera Hoffman · Reveal Pharma$14,477,163
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
- Gonul Velicelebi · Sanford Burnham Prebys Medical Discovery Institute$8,970,452
Research focus
RattusAddictionOpioid UseBehaviorOpiate AddictionHeroinMediatingOpioidPharmaceutical PreparationsSelf AdministrationOxycodoneOpioid Use DisorderAffectMorphineAnalgesicsAmygdaloid StructureAdverse OutcomeAllelesBiologicalBrain DiseasesAlgorithmsBehavioral StudyBehavioralArea
Grant awards (7)
Development of cebranopadol, a potent dual MOP/NOP agonist, for the treatment of Opioid Use Disorder (OUD)$3,324,591
UG3 · FY2024 · DA
Development of cebranopadol, a potent dual MOP/NOP agonist, for the treatment of Opioid Use Disorder (OUD)$3,329,591
UG3 · FY2023 · DA
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model$782,581
U01 · FY2022 · DA
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model$921,821
U01 · FY2021 · DA
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model$852,370
U01 · FY2020 · DA
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model$771,565
U01 · FY2019 · DA
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model$787,748
U01 · FY2018 · DA